Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.076
+0.076 (3.80%)
Sep 15, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Research and Development of Pharmaceutical Products
20.12M
Log In
Log In
Log In
Log In
Upgrade
Research and Development of Pharmaceutical Products Growth
-67.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
France
20.12M
Log In
Log In
Log In
Log In
Upgrade
France Growth
-67.36%
Log In
Log In
Log In
Log In
Upgrade